Production (Stage)
Hemostemix Inc.
HEM.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -933.70K | -230.60K | -379.50K | -352.70K | -502.50K |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 343.80K | 118.20K | 115.60K | 107.90K | 36.10K |
| Change in Net Operating Assets | -703.30K | 82.80K | 314.10K | 155.50K | 289.60K |
| Cash from Operations | -1.29M | -29.60K | 50.20K | -89.30K | -176.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.45M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -59.80K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 78.10K |
| Cash from Financing | 1.75M | -- | -- | -- | 13.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 458.90K | -29.60K | 50.20K | -89.30K | -163.30K |